Get the Stockscreener App
372.97
5.71%
20.14
After Hours:
372.73
-0.24
-0.06%
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corp stock is traded at $372.97, with a volume of 185.30M.
It is up +5.71% in the last 24 hours and down -10.35% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$352.83
Open:
$357.15
24h Volume:
185.30M
Relative Volume:
4.82
Market Cap:
$2.77T
Revenue:
$318.27B
Net Income/Loss:
$125.22B
P/E Ratio:
22.21
EPS:
16.79
Net Cash Flow:
$72.92B
1W Performance:
-1.69%
1M Performance:
-10.35%
6M Performance:
-23.53%
1Y Performance:
-25.02%
1-Day Range:
$355.43
$376.61
1-Week Range:
$349.20
$381.63
52-Week Range:
$349.20
$555.45
Microsoft Corp Stock (MSFT) Company Profile
Name
Microsoft Corp
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corp
|
372.97 | 2.62T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
148.53 | 439.16B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
112.93 | 257.16B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
701.09 | 172.76B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
151.35 | 109.85B | 7.11B | 1.95B | 2.44B | 2.5883 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-01-26 | Initiated | Citizens | Mkt Outperform |
| Apr-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-30-26 | Reiterated | Barclays | Overweight |
| Apr-30-26 | Reiterated | Bernstein | Outperform |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Deutsche Bank | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Stifel | Hold |
| Apr-30-26 | Reiterated | The Benchmark Company | Buy |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-28-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-26 | Reiterated | Citigroup | Buy |
| Apr-15-26 | Reiterated | Robert W. Baird | Outperform |
| Apr-14-26 | Reiterated | Mizuho | Outperform |
| Apr-14-26 | Reiterated | Piper Sandler | Overweight |
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corp Stock (MSFT) Latest News
Why Microsoft Stock Rose Today - Yahoo Finance
Microsoft once spent $150 million to keep Apple alive, and it wasn't out of kindness - XDA
A Look at Microsoft Corp (MSFT) After 5.7% Gain -- GF Value $558 - GuruFocus
Stocks Waver as the AI Invoice Starts Changing Hands - Investing.com
Microsoft beefs up Copilot for finance work in Excel - CFO Dive
Microsoft's Worst Month Since 2000 Meets Micron's Record NumbersMicrosoft (NASDAQ:MSFT), Micron Techno - Benzinga
OpenAI and Microsoft Sued for Mass Copyright Infringement by News Publisher Coalition - Yahoo
Microsoft Corporation (MSFT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Microsoft raises prices due to AI pressure; Italian regulator investigates Microsoft 365 subscription - marketscreener.com
Microsoft Lost $1.3T: Here Is How Much The Mispricing Is Worth (Upgrade) (NASDAQ:MSFT) - Seeking Alpha
Bullish spending intentions for Microsoft, Amazon in 2026: Jefferies - Seeking Alpha
IBM, Microsoft Share Gains Lead Dow's 161-Point Climb - Moomoo
Microsoft Corp Stock (MSFT) Moved Up by 4.82% on Jun 26: Key Drivers Unveiled - TradingKey
The Hidden Turbulence Priced Into Microsoft Stock - Trefis
Microsoft stock hits one-year low amid AI spending concerns - qz.com
MSFT Shareholder Alert: Microsoft Corporation Securities - GlobeNewswire
Microsoft worker emails thousands of colleagues about company's support for genocidal 'Israel' - thecanary.co
Microsoft Extends FREE Windows 10 Security Updates Until 2027 - LinkedIn
McGuireWoods Advises Chevron in Landmark Power Purchase Deal With Microsoft for West Texas Data Center - McGuireWoods
How Microsoft Cuts Water Use While Scaling Data Centres - Sustainability Magazine
US OPEN: Is the Software making a comeback❓Strong rebound for Microsoft and Palantir shares - XTB.com
Microsoft faces Italy antitrust probe over subscription prices By Investing.com - Investing.com Nigeria
Microsoft (MSFT) Faces Antitrust Investigation in Italy Over Mic - GuruFocus
Wall Street Analysts Think Microsoft (MSFT) Is a Good Investment: Is It? - Yahoo! Finance Canada
Microsoft (MSFT) Faces Challenges Amidst Tech Sector Declines - GuruFocus
Microsoft faces Italy antitrust probe over subscription prices - Investing.com
Why Are Investors Buying Micron Instead Of Microsoft? Dan Ives Explains The AI Trade SplitMeta Platfor - Benzinga
Italy opens probe into Microsoft over subscription price increase By Investing.com - Investing.com Canada
Italy opens probe into Microsoft over subscription price increase - Investing.com
Profitable Move in Microsoft (MSFT) Options Trading - GuruFocus
Italy probes Microsoft over 365 AI pricing - grafa.com
Microsoft Probed in Italy Over Pricing of AI Bundles -- Update - marketscreener.com
Microsoft Corp (NASDAQ:MSFT) Shines as a Quality Investment Through Caviar Cruise Screening - ChartMill
Tech Bytes: Hardware price increases for Apple and Microsoft - WDIO.com
‘Maleficent 7’? Analyst Warns Microsoft Could Crash To $250 - Benzinga
Microsoft (MSFT) Faces Government Scrutiny Over AI Model Release - GuruFocus
Amazon: Mr. Market Is Giving Them The Microsoft Treatment And He's Wrong - Seeking Alpha
Italy probes AI-fueled price hikes in Microsoft 365 - The Register
How Big is Microsoft’s US Data Centre Footprint? - Data Centre Magazine
The Mag 7 Trade Is Ending - Investing.com
Microsoft is turning Windows 11 into an AI operating system - Computerworld
Microsoft Faces Regulatory Scrutiny Over Misleading Pricing Tact - GuruFocus
Italy Investigates Microsoft (MSFT) Over Microsoft 365 Pricing P - GuruFocus
Investigating Microsoft's Standing In Software Industry Compared To Competitors - Benzinga
How Low Can Microsoft Stock Go? - Trefis
Microsoft Warns of Photo ZIP Phishing Campaign Targeting Hotels with Node.js Implant - The Hacker News
Why Apple and Microsoft Are Raising Product Prices While This Little-Known Chipmaker Makes Billions - inc.com
Microsoft Stock Price Trend Forecast: Stock Price Fell Over 20% Cumulatively in June, $345 Becomes Key Bull-Bear Pivot Point - TradingKey
Italy Investigates Microsoft (MSFT) Over Unfair Pricing Practices - GuruFocus
Is Microsoft (MSFT) One of the Best Stocks For Beginners to Buy Now? - Insider Monkey
Microsoft Faces Antitrust Investigation Over Microsoft 365 Prici - GuruFocus
Microsoft Corp Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.58%
5.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):